CN104997753A - 一种用于免疫抑制的环孢素软胶囊剂及其制备方法 - Google Patents
一种用于免疫抑制的环孢素软胶囊剂及其制备方法 Download PDFInfo
- Publication number
- CN104997753A CN104997753A CN201510468840.5A CN201510468840A CN104997753A CN 104997753 A CN104997753 A CN 104997753A CN 201510468840 A CN201510468840 A CN 201510468840A CN 104997753 A CN104997753 A CN 104997753A
- Authority
- CN
- China
- Prior art keywords
- ciclosporin
- soft capsules
- capsule
- agent according
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title claims abstract description 63
- 108010036949 Cyclosporine Proteins 0.000 title claims abstract description 61
- 229960001265 ciclosporin Drugs 0.000 title claims abstract description 61
- 239000007901 soft capsule Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 229930182912 cyclosporin Natural products 0.000 title abstract 5
- 206010062016 Immunosuppression Diseases 0.000 title abstract 2
- 230000001506 immunosuppresive effect Effects 0.000 title abstract 2
- 229920001983 poloxamer Polymers 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 16
- 239000002775 capsule Substances 0.000 claims abstract description 15
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960000502 poloxamer Drugs 0.000 claims abstract description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- 239000003795 chemical substances by application Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 108010010803 Gelatin Proteins 0.000 claims description 17
- 239000008273 gelatin Substances 0.000 claims description 17
- 229920000159 gelatin Polymers 0.000 claims description 17
- 235000019322 gelatine Nutrition 0.000 claims description 17
- 235000011852 gelatine desserts Nutrition 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 12
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 10
- 239000000600 sorbitol Substances 0.000 claims description 10
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 229920001971 elastomer Polymers 0.000 claims description 6
- 239000003292 glue Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 244000173166 Pyrus ussuriensis Species 0.000 claims description 2
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract description 15
- -1 Polyoxyethylene Polymers 0.000 abstract description 8
- 239000004094 surface-active agent Substances 0.000 abstract description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 5
- 239000004359 castor oil Substances 0.000 abstract description 4
- 235000019438 castor oil Nutrition 0.000 abstract description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 8
- 229960004756 ethanol Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000012467 final product Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical class CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 3
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000004530 micro-emulsion Substances 0.000 description 3
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 229930105110 Cyclosporin A Natural products 0.000 description 2
- 206010029155 Nephropathy toxic Diseases 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100000304 hepatotoxicity Toxicity 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000007056 liver toxicity Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 231100000417 nephrotoxicity Toxicity 0.000 description 2
- 230000007694 nephrotoxicity Effects 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 238000004094 preconcentration Methods 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510468840.5A CN104997753B (zh) | 2015-08-03 | 2015-08-03 | 一种用于免疫抑制的环孢素软胶囊剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510468840.5A CN104997753B (zh) | 2015-08-03 | 2015-08-03 | 一种用于免疫抑制的环孢素软胶囊剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104997753A true CN104997753A (zh) | 2015-10-28 |
CN104997753B CN104997753B (zh) | 2017-12-26 |
Family
ID=54370799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510468840.5A Active CN104997753B (zh) | 2015-08-03 | 2015-08-03 | 一种用于免疫抑制的环孢素软胶囊剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104997753B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1504239A (zh) * | 2002-12-04 | 2004-06-16 | 比奥马克斯公司 | 改进的环孢菌素药物组合物的载体系统 |
CN100998864A (zh) * | 2006-12-26 | 2007-07-18 | 沈阳药科大学 | 一种环孢菌素a半固体骨架胶囊及其制备方法 |
CN101130059A (zh) * | 2007-08-16 | 2008-02-27 | 江苏信孚药业有限公司 | 一种环孢素a的自微乳化软胶囊及其制备方法 |
EP2193798A1 (en) * | 2007-09-10 | 2010-06-09 | Maruho Co., Ltd. | Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
CN102284062A (zh) * | 2010-09-21 | 2011-12-21 | 深圳信立泰药业股份有限公司 | 一种含环孢素的软胶囊囊壳组合物及制备方法和由其制成的含环孢素的软胶囊 |
CN103656617A (zh) * | 2012-09-26 | 2014-03-26 | 沈阳兴齐眼药股份有限公司 | 一种环孢素眼用溶液的制备方法 |
-
2015
- 2015-08-03 CN CN201510468840.5A patent/CN104997753B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1504239A (zh) * | 2002-12-04 | 2004-06-16 | 比奥马克斯公司 | 改进的环孢菌素药物组合物的载体系统 |
CN100998864A (zh) * | 2006-12-26 | 2007-07-18 | 沈阳药科大学 | 一种环孢菌素a半固体骨架胶囊及其制备方法 |
CN101130059A (zh) * | 2007-08-16 | 2008-02-27 | 江苏信孚药业有限公司 | 一种环孢素a的自微乳化软胶囊及其制备方法 |
EP2193798A1 (en) * | 2007-09-10 | 2010-06-09 | Maruho Co., Ltd. | Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
CN102284062A (zh) * | 2010-09-21 | 2011-12-21 | 深圳信立泰药业股份有限公司 | 一种含环孢素的软胶囊囊壳组合物及制备方法和由其制成的含环孢素的软胶囊 |
CN103656617A (zh) * | 2012-09-26 | 2014-03-26 | 沈阳兴齐眼药股份有限公司 | 一种环孢素眼用溶液的制备方法 |
Non-Patent Citations (1)
Title |
---|
CHEN Y.,ET AL.: "Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: Preparation, characterization, in vitro corneal penetration and ocular irritation", 《JOURNAL OF DRUG TARGETING》 * |
Also Published As
Publication number | Publication date |
---|---|
CN104997753B (zh) | 2017-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1332648C (zh) | 微乳预浓缩物 | |
EP2062571B1 (en) | Self-emulsifying pharmaceutical composition with enhanced bioavailability | |
CN101862306A (zh) | 新型难溶性药物口服固体自乳化制剂及其制备方法 | |
US20020025927A1 (en) | Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them | |
TW200422057A (en) | Composition in form of emulsion or microemulsion pre-concentrate for oral administration and its uses | |
KR0183449B1 (ko) | 사이클로스포린-함유 연질캅셀제 | |
CN101103962A (zh) | 长春西汀口服自微乳化释药系统及其制备方法 | |
CN105688220A (zh) | 一种含丁苯酞与新型增溶剂的药物组合物 | |
CN101130059A (zh) | 一种环孢素a的自微乳化软胶囊及其制备方法 | |
WO2001032142A1 (en) | Cyclosporin formulation | |
CN105125489B (zh) | 包含阿拉泊韦的药物组合物 | |
CA2249675A1 (en) | A novel composition containing cyclosporin | |
WO2015121378A1 (en) | Liquid phospholipid-containing compositions for the preparation of pharmaceuticals | |
DE60018715T2 (de) | Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil | |
CN102772364A (zh) | 帕立骨化醇的脂肪乳及其制剂和制备方法 | |
CN104997753A (zh) | 一种用于免疫抑制的环孢素软胶囊剂及其制备方法 | |
CN102008713B (zh) | 环孢素a前体脂质体、药物组合物及其制备方法 | |
WO2015121381A1 (en) | Capsules containing high doses of krill phospholipids | |
CN104055749B (zh) | 环孢素a的自微乳化软胶囊内容物组合及其制备方法 | |
Chengaiah et al. | Self emulsifying drug delivery system: a novel approach for drug delivery | |
CN100366260C (zh) | 黄芪甲苷脂肪乳及其制备工艺 | |
CN103784405B (zh) | 一种改善利塞膦酸钠口服生物利用度的制剂及其制备方法 | |
CN106606780B (zh) | 多烯磷脂酰胆碱组合物和软胶囊及制备方法 | |
CN103169657A (zh) | 一种含灯盏花素磷脂复合物的自乳化剂及其制备方法和用途 | |
CN107970225B (zh) | 一种达比加群酯固体脂质纳米粒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Wenjun Inventor before: Sun Hao |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171130 Address after: Hangzhou City, Zhejiang province 310052 Binjiang District Puyan Street six road No. 368 building two building E2005 room (South) Applicant after: Zhejiang Kang Bai Yu Biotechnology Co. Ltd. Address before: 211224 Nanjing Feng Feng Pharmaceutical Industry Co., Ltd., 18 crystal Town Industrial Park, Lishui District, Jiangsu, Nanjing Applicant before: Sun Hao |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant |